From October 24th to 26th, 2023, a major event in the global pharmaceutical industry, CPHI Worldwide, was successfully held in Barcelona, Spain. As the world's largest pharmaceutical trade exhibition, this event successfully attracted representatives, pharmaceutical experts, and relevant participants from 167 countries/regions, with a total of over 40,000 attendees collaborating and exploring the latest trends in the pharmaceutical industry.
Dorrapharma, a renowned company that has entrenched itself in the European market for nearly 20 years, once again demonstrated its leading presence in the European pharmaceutical sector during this show. Whether long-time clients or new partners, Dorrapharma has earned numerous accolades for its outstanding expertise and enthusiastic service.
During the exhibition, the Dorrapharma team comprehensively introduced the company's strengths in platform services, supply chain services and CDMO services to clients from around the world. Together, they discussed Dorrapharma's experiences in R&D, production, and regulatory registration. The company's precise product strategy and continuous pursuit of product quality earned high praise from customers, laying a solid foundation for future collaborations. Following the principle of customer centricity, Dorrapharma continuously refines its market strategy and accurately positions itself to successfully expand its presence in the global market.
With the successful conclusion of CPHI Worldwide Barcelona, Dorrapharma has embarked on a new journey. We are committed to creating more valuable products for the health of life. We look forward to reuniting in Milan in 2024!
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1